Literature DB >> 14962525

Epigenetic differences between Wilms' tumours in white and east-Asian children.

Ryuji Fukuzawa1, Norman E Breslow, Ian M Morison, Patrick Dwyer, Takeshi Kusafuka, Yasutsugu Kobayashi, David M Becroft, J Bruce Beckwith, Elizabeth J Perlman, Anthony E Reeve.   

Abstract

BACKGROUND: Variations in the international incidence of Wilms' tumour might be due to genetic factors. The maternal insulin-like growth factor 2 gene (IGF2) is imprinted in normal tissues, whereas in some Wilms' tumours and other tumour types the imprint is lost, leading to biallelic transcription of IGF2. We investigated whether the difference in incidence of Wilms' tumour between children of east-Asian descent and white children is due to variations in proportion of tumours with loss of IGF2 imprinting (IGF2 LOI).
METHODS: We assessed IGF2 LOI by use of an ApaI polymorphism in IGF2 exon 9 or quantitative PCR measuring DNA methylation of the H19 and KvDMR1 alleles. The frequencies of perilobar nephrogenic rests associated with Wilms' tumour were assessed histologically in Japanese children and children of white and east-Asian descent.
FINDINGS: IGF2 LOI was present in Wilms' tumours from predominantly white children from New Zealand (13 of 41 tumours) but absent in tumours from Japanese children (0 of 21 tumours; difference in proportions 0.32, 95% CI 0.07-0.52). Frequency of perilobar nephrogenic rests accompanying tumours from white American children (1192 of 5002, 24%) was significantly higher than in Japanese (one of 56, 1%, difference in proportions 0.22, 95% CI 0.14-0.25) and east-Asian American children (seven of 92, 8%, 0.16, 0.09-0.21).
INTERPRETATION: Wilms' tumours in the east-Asian population rarely arise from the IGF2 LOI mechanism frequently noted in white patients. Our findings that IGF2 LOI and perilobar nephrogenic rests associated with this mechanism arise at low frequency in Japanese and east-Asian American children lend support to this conclusion. Variation in frequency of this epigenetic mechanism provides one explanation for the difference in incidence of Wilms' tumour between populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962525     DOI: 10.1016/S0140-6736(04)15491-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  24 in total

1.  Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.

Authors:  Masayuki Haruta; Yasuhito Arai; Naoki Watanabe; Yuiko Fujiwara; Shohei Honda; Junjiro Ohshima; Fumio Kasai; Hisaya Nakadate; Hiroshi Horie; Hajime Okita; Jun-Ichi Hata; Masahiro Fukuzawa; Yasuhiko Kaneko
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

2.  WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.

Authors:  Elizabeth J Perlman; Paul E Grundy; James R Anderson; Lawrence J Jennings; Daniel M Green; Jeffrey S Dome; Robert C Shamberger; E Cristy Ruteshouser; Vicki Huff
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

3.  Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.

Authors:  Raisa Vuononvirta; Neil J Sebire; Anthony R Dallosso; Jorge S Reis-Filho; Richard D Williams; Alan Mackay; Kerry Fenwick; Anita Grigoriadis; Alan Ashworth; Kathy Pritchard-Jones; Keith W Brown; Gordan M Vujanic; Chris Jones
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

4.  Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India.

Authors:  Elanthenral Sigamani; Mohammad Nahidul Wari; Venkateswaran K Iyer; Sandeep Agarwala; Arundhati Sharma; Sameer Bakhshi; Amit Dinda
Journal:  Pediatr Surg Int       Date:  2013-01-05       Impact factor: 1.827

5.  Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.

Authors:  Norman E Breslow; J Bruce Beckwith; Elizabeth J Perlman; Anthony E Reeve
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

Review 6.  Children's Oncology Group's 2013 blueprint for research: renal tumors.

Authors:  Jeffrey S Dome; Conrad V Fernandez; Elizabeth A Mullen; John A Kalapurakal; James I Geller; Vicki Huff; Eric J Gratias; David B Dix; Peter F Ehrlich; Geetika Khanna; Marcio H Malogolowkin; James R Anderson; Arlene Naranjo; Elizabeth J Perlman
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

7.  Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.

Authors:  Hans T Bjornsson; Lindsey J Brown; M Danielle Fallin; Michael A Rongione; Marina Bibikova; Eliza Wickham; Jian-Bing Fan; Andrew P Feinberg
Journal:  J Natl Cancer Inst       Date:  2007-08-08       Impact factor: 13.506

8.  Fetal programming and Wilms tumor.

Authors:  Julia E Heck; Di He; Carla Janzen; Noah Federman; Jorn Olsen; Beate Ritz; Johnni Hansen
Journal:  Pediatr Blood Cancer       Date:  2018-09-25       Impact factor: 3.167

9.  Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.

Authors:  Samantha Gadd; Vicki Huff; Chiang-Ching Huang; E Cristy Ruteshouser; Jeffrey S Dome; Paul E Grundy; Norman Breslow; Lawrence Jennings; Daniel M Green; J Bruce Beckwith; Elizabeth J Perlman
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

10.  Social and biological factors influencing the outcomes of children with Wilms tumors in Kenya and other Sub-Saharan countries.

Authors:  Kazuko Kumon; Yasuhiko Kaneko
Journal:  Transl Pediatr       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.